Literature DB >> 19127596

Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact?

Marc T Goodman1, Yurii B Shvetsov.   

Abstract

Papillary serous carcinoma of the peritoneum (PSCP) has been recognized for almost 5 decades, but little is known about the etiology or pathogenesis of this uncommon malignancy. The objective of this analysis was to examine trends in the incidence of PSCP in the United States. Invasive PSCP cases (N = 4,389) were identified through 24 population-based registries in the United States during the period 1995-2004. Incidence rates were calculated per million population. PSCP is a disease of older women, with few cases diagnosed before the age of 40 years. The incidence of PSCP was 64% lower among black women and 47% lower among Asian-Pacific Islander women compared with white women. Rates among Hispanic women were 39% lower than among non-Hispanic women. The majority of PSCP (68%) was diagnosed at a distant stage, underscoring the difficulty of diagnosing this malignancy. The incidence of PSCP has increased dramatically during the past decade in the United States with the greatest rise (>13% per year) among non-Hispanic and white women. This trend was more pronounced among older women and women with early stage disease. The incidence of PSCP shows substantial racial and ethnic diversity. The increase in the rate of PSCP among all racial and ethnic groups during the 10-year observation period is cause for some alarm. Although the reason for this temporal trend is unknown, some of the increase may be attributable to reclassification of ovarian carcinoma to the peritoneum. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19127596      PMCID: PMC2723055          DOI: 10.1002/ijc.24184

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report.

Authors:  M SWERDLOW
Journal:  Am J Obstet Gynecol       Date:  1959-01       Impact factor: 8.661

2.  Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

Authors:  David W Kindelberger; Yonghee Lee; Alexander Miron; Michelle S Hirsch; Colleen Feltmate; Fabiola Medeiros; Michael J Callahan; Elizabeth O Garner; Robert W Gordon; Chandler Birch; Ross S Berkowitz; Michael G Muto; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

3.  Estimating average annual percent change for disease rates without assuming constant change.

Authors:  Michael P Fay; Ram C Tiwari; Eric J Feuer; Zhaohui Zou
Journal:  Biometrics       Date:  2006-09       Impact factor: 2.571

4.  The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

Authors:  Fabiola Medeiros; Michael G Muto; Yonghee Lee; Julia A Elvin; Michael J Callahan; Colleen Feltmate; Judy E Garber; Daniel W Cramer; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2006-02       Impact factor: 6.394

5.  Confidence intervals for directly standardized rates: a method based on the gamma distribution.

Authors:  M P Fay; E J Feuer
Journal:  Stat Med       Date:  1997-04-15       Impact factor: 2.373

6.  Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer.

Authors:  G H Eltabbakh; M S Piver; N Natarajan; C J Mettlin
Journal:  Obstet Gynecol       Date:  1998-02       Impact factor: 7.661

7.  Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum.

Authors:  M G Muto; W R Welch; S C Mok; C A Bandera; P M Fishbaugh; S W Tsao; C C Lau; H M Goodman; R C Knapp; R S Berkowitz
Journal:  Cancer Res       Date:  1995-02-01       Impact factor: 12.701

8.  Papillary serous carcinoma in ovaries of normal size: a clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma.

Authors:  Chel Hun Choi; Tae-Joong Kim; Woo Young Kim; Geung Hwan Ahn; Jeong-Won Lee; Byoung-Gie Kim; Je-Ho Lee; Duk-Soo Bae
Journal:  Gynecol Oncol       Date:  2007-03-26       Impact factor: 5.482

9.  Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations.

Authors:  J O Schorge; M G Muto; W R Welch; C A Bandera; S C Rubin; D A Bell; R S Berkowitz; S C Mok
Journal:  J Natl Cancer Inst       Date:  1998-06-03       Impact factor: 13.506

10.  BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum.

Authors:  C A Bandera; M G Muto; J O Schorge; R S Berkowitz; S C Rubin; S C Mok
Journal:  Obstet Gynecol       Date:  1998-10       Impact factor: 7.661

View more
  8 in total

1.  Primary peritoneal serous carcinoma: a rare case and palliative approach.

Authors:  Viral M Bhanvadia; Jignesh K Parmar; Yogendra G Madan; Shamim S Sheikh
Journal:  Indian J Palliat Care       Date:  2014-05

2.  Primary peritoneal and ovarian cancers: an epidemiological comparative analysis.

Authors:  Delores J Grant; Patricia G Moorman; Lucy Akushevich; Rachel T Palmieri; Rex C Bentley; Joellen M Schildkraut
Journal:  Cancer Causes Control       Date:  2010-03-23       Impact factor: 2.506

3.  Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.

Authors:  Suzanne C Dixon; Christina M Nagle; Aaron P Thrift; Paul Dp Pharoah; Celeste Leigh Pearce; Wei Zheng; Jodie N Painter; Georgia Chenevix-Trench; Peter A Fasching; Matthias W Beckmann; Diether Lambrechts; Ignace Vergote; Sandrina Lambrechts; Els Van Nieuwenhuysen; Mary Anne Rossing; Jennifer A Doherty; Kristine G Wicklund; Jenny Chang-Claude; Anja Rudolph; Kirsten B Moysich; Kunle Odunsi; Marc T Goodman; Lynne R Wilkens; Pamela J Thompson; Yurii B Shvetsov; Thilo Dörk; Tjoung-Won Park-Simon; Peter Hillemanns; Natalia Bogdanova; Ralf Butzow; Heli Nevanlinna; Liisa M Pelttari; Arto Leminen; Francesmary Modugno; Roberta B Ness; Robert P Edwards; Joseph L Kelley; Florian Heitz; Beth Y Karlan; Susanne K Kjær; Estrid Høgdall; Allan Jensen; Ellen L Goode; Brooke L Fridley; Julie M Cunningham; Stacey J Winham; Graham G Giles; Fiona Bruinsma; Roger L Milne; Melissa C Southey; Michelle A T Hildebrandt; Xifeng Wu; Karen H Lu; Dong Liang; Douglas A Levine; Maria Bisogna; Joellen M Schildkraut; Andrew Berchuck; Daniel W Cramer; Kathryn L Terry; Elisa V Bandera; Sara H Olson; Helga B Salvesen; Liv Cecilie Thomsen; Reidun K Kopperud; Line Bjorge; Lambertus A Kiemeney; Leon F A G Massuger; Tanja Pejovic; Linda S Cook; Nhu D Le; Kenneth D Swenerton; Angela Brooks-Wilson; Linda E Kelemen; Jan Lubiński; Tomasz Huzarski; Jacek Gronwald; Janusz Menkiszak; Nicolas Wentzensen; Louise Brinton; Hannah Yang; Jolanta Lissowska; Claus K Høgdall; Lene Lundvall; Honglin Song; Jonathan P Tyrer; Ian Campbell; Diana Eccles; James Paul; Rosalind Glasspool; Nadeem Siddiqui; Alice S Whittemore; Weiva Sieh; Valerie McGuire; Joseph H Rothstein; Steven A Narod; Catherine Phelan; Harvey A Risch; John R McLaughlin; Hoda Anton-Culver; Argyrios Ziogas; Usha Menon; Simon A Gayther; Susan J Ramus; Aleksandra Gentry-Maharaj; Anna H Wu; Malcolm C Pike; Chiu-Chen Tseng; Jolanta Kupryjanczyk; Agnieszka Dansonka-Mieszkowska; Agnieszka Budzilowska; Beata Spiewankiewicz; Penelope M Webb
Journal:  Int J Epidemiol       Date:  2016-07-10       Impact factor: 7.196

4.  The Effects of Active Hexose Correlated Compound (AHCC) on Levels of CD4+ and CD8+ in Patients with Epithelial Ovarian Cancer or Peritoneal Cancer Receiving Platinum Based Chemotherapy

Authors:  Wineeya Suknikhom; Ruangsak Lertkhachonsuk; Tarinee Manchana
Journal:  Asian Pac J Cancer Prev       Date:  2017-03-01

5.  Inguinal Lymph Node Metastasis of a Primary Serous Papillary Carcinoma of the Peritoneum One Year after CRS and HIPEC.

Authors:  Shadi Katou; Mathilde Feist; Wieland Raue; Johann Pratschke; Beate Rau; Andreas Brandl
Journal:  Visc Med       Date:  2018-01-31

6.  Primary Peritoneal Carcinoma in a BRCA1/2-negative, PALB2-positive patient.

Authors:  Ryan Kahn; Arlene Garcia-Soto; Rachel Silva-Smith; Andre Pinto; Sophia H L George
Journal:  Gynecol Oncol Rep       Date:  2016-08-02

7.  Genetic landscape of a case of extraovarian peritoneal serous papillary carcinoma.

Authors:  Zhongping Cheng; Weihong Yang; Jing Guo; Ning Luo; Li Chen; Yan Xie; Xiaoyan Qu; Liping Hu; Hong Dai; Xiaoming Zuo
Journal:  Oncol Lett       Date:  2016-08-02       Impact factor: 2.967

8.  Primary peritoneal clear cell carcinoma treated with IMRT and interstitial HDR brachytherapy: a case report.

Authors:  Skyler B Johnson; Joann I Prisciandaro; Jessica Zhou; Scott W Hadley; R Kevin Reynolds; Shruti Jolly
Journal:  J Appl Clin Med Phys       Date:  2014-01-06       Impact factor: 2.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.